Antiviral activity of chondroitin sulphate E targeting dengue virus envelope protein (Q40348272)

19 September 2017

title

Antiviral activity of chondroitin sulphate E targeting dengue virus envelope protein (English)

1 reference

19 September 2017

0 references

10

Takashi Suzuki

1 reference

19 September 2017

4

Masataka Arihara

1 reference

19 September 2017

Daisuke Kato

1

1 reference

19 September 2017

Shota Era

2

1 reference

19 September 2017

Ippei Watanabe

3

1 reference

19 September 2017

Nobuo Sugiura

5

1 reference

19 September 2017

Koji Kimata

6

1 reference

19 September 2017

Yasuo Suzuki

7

1 reference

19 September 2017

Kouichi Morita

8

1 reference

19 September 2017

Kazuya I. P J. Hidari

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20851716

16 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20851716

16 July 2024

publication date

21 September 2010

1 reference

full work available at URL

19 September 2017

https://api.elsevier.com/content/article/PII:S0166354210007060?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

https://api.elsevier.com/content/article/PII:S0166354210007060?httpAccept=text/plain

16 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

16 July 2024

1 reference

19 September 2017

volume

88

1 reference

19 September 2017

issue

2

1 reference

19 September 2017

page(s)

236-243

1 reference

Isolation of a Singh's Aedes albopictus cell clone sensitive to Dengue and Chikungunya viruses

19 September 2017

cites work

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1099/0022-1317-40-3-531

Virus attachment and entry offer numerous targets for antiviral therapy

1

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Identification and characterization of carbohydrate molecules in mammalian cells recognized by dengue virus type 2.

16 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Secreted NS1 of Dengue Virus Attaches to the Surface of Cells via Interactions with Heparan Sulfate and Chondroitin Sulfate E

16 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Antiviral Peptides Targeting the West Nile Virus Envelope Protein

16 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Chondroitin sulfate characterized by the E-disaccharide unit is a potent inhibitor of herpes simplex virus infectivity and provides the virus binding sites on gro2C cells

16 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate

16 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein.

16 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

The envelope glycoprotein domain III of dengue virus serotypes 1 and 2 inhibit virus entry

16 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Alpha-glucosidase inhibitors reduce dengue virus production by affecting the initial steps of virion morphogenesis in the endoplasmic reticulum

16 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells

16 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Specific molecular interactions of oversulfated chondroitin sulfate E with various heparin-binding growth factors. Implications as a physiological binding partner in the brain and other tissues

16 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Structure and function of heparan sulphate proteoglycans

16 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Heparan sulfate-mediated binding of infectious dengue virus type 2 and yellow fever virus

16 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century

16 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

16 July 2024

Dengue

15

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Structure and anti-dengue virus activity of sulfated polysaccharide from a marine alga

16 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Peptide inhibitors of dengue virus and West Nile virus infectivity

16 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Matrix proteoglycans: from molecular design to cellular function

16 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Novel tetrasaccharides isolated from squid cartilage chondroitin sulfate E contain unusual sulfated disaccharide units GlcA(3-O-sulfate)beta1-3GalNAc(6-O-sulfate) or GlcA(3-O-sulfate)beta1-3GalNAc

16 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Proteoglycans: structures and interactions

16 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Peptide inhibitors of West Nile NS3 protease: SAR study of tetrapeptide aldehyde inhibitors

16 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Structure of dengue virus: implications for flavivirus organization, maturation, and fusion

16 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Phylogeny of the genus Flavivirus

16 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

16 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses

16 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Substitutions at the putative receptor-binding site of an encephalitic flavivirus alter virulence and host cell tropism and reveal a role for glycosaminoglycans in entry

16 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virus

16 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

The Fusion glycoprotein shell of Semliki Forest virus: an icosahedral assembly primed for fusogenic activation at endosomal pH

16 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Heparin inhibits dengue-2 virus infection of five human liver cell lines

16 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Molecular biology of flaviviruses

16 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Differential binding efficiency between the envelope protein of Japanese encephalitis virus variants and heparan sulfate on the cell surface.

16 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Binding of herpes simplex virus to cellular heparan sulphate, an initial step in the adsorption process

16 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses

16 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Adaptation of tick-borne encephalitis virus to BHK-21 cells results in the formation of multiple heparan sulfate binding sites in the envelope protein and attenuation in vivo

16 July 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Probing the interaction of dengue virus envelope protein with heparin: assessment of glycosaminoglycan-derived inhibitors

16 July 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

The molecular basis of virulence of the encephalitogenic flaviviruses

16 July 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

A structural perspective of the flavivirus life cycle

16 July 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

A ligand-binding pocket in the dengue virus envelope glycoprotein

16 July 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein

16 July 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Chondroitin 4-O-sulfotransferase-1 modulates Wnt-3a signaling through control of E disaccharide expression of chondroitin sulfate

16 July 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

A small molecule fusion inhibitor of dengue virus

16 July 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution

16 July 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120-gp41.

16 July 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia

16 July 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

DNA sequencing with chain-terminating inhibitors

16 July 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Cellular receptors for viruses: links to tropism and pathogenesis

16 July 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Characterization of a Structural Intermediate of Flavivirus Membrane Fusion

16 July 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Highly sulfated forms of heparin sulfate are involved in japanese encephalitis virus infection.

16 July 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell.

16 July 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Detection of the disease severity-related molecular differences among new Thai dengue-2 isolates in 1993, based on their structural proteins and major non-structural protein NS1 sequences

16 July 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Localization of a functional site on herpes simplex virus type 1 glycoprotein C involved in binding to cell surface heparan sulphate

16 July 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

A small-molecule dengue virus entry inhibitor

16 July 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Transmission cycles, host range, evolution and emergence of arboviral disease

16 July 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo

16 July 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Antiviral effects of an iminosugar derivative on flavivirus infections

16 July 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Structural basis of a flavivirus recognized by its neutralizing antibody: solution structure of the domain III of the Japanese encephalitis virus envelope protein

16 July 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Identification of novel target sites and an inhibitor of the dengue virus E protein

16 July 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Potent inhibition of NTPase/helicase of the West Nile Virus by ring-expanded ("fat") nucleoside analogues

16 July 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Visualization of membrane protein domains by cryo-electron microscopy of dengue virus

16 July 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

Structures of immature flavivirus particles

16 July 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.09.002

16 July 2024

Identifiers

1 reference

19 September 2017

1 reference